Peter Blume-Jensen, CEO of Acrivon Therapeutics ACRV, has filed 1 purchase and 0 sales on the open market. Over the past 12 months that comes to a net purchase of $82.3K. The latest trade was on 05/21.

PB

PB

Peter Blume-Jensen

President and CEO

Company

Acrivon Therapeutics ACRV

First filing

23/06/01

Trades

38 trades

Buys / sales

1 / 0

12-month net buying

$82.3K

Last trade

05/21

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Acrivon TherapeuticsACRV	Open-market buy	01/14	01/16	49,000 sh	$1.68	$82,320	+2.4%